JPRN-UMIN000000822已完成1 期
A phase I/IIa study of heat immunotherapy using anti-melanoma antibody conjugated magnetoliposome for advanced melanoma patients - A phase I/IIa study of heat immunotherapy using anti-melanoma antibody conjugated magnetoliposome for advanced melanoma patients
Department of Dermatology, Shinshu University School of Medicine0 个研究点目标入组 6 人开始时间: 2007年9月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. An anti-cancer therapy has been received within previous 4 weeks 2. Patients who have brain metastases 3. Patients who have a life expectancy of less than 6 months 4. Patients who are pregnant or nursing 5. Patients who have severe pleural or pericardial effusion or ascites 6. Patients who have active infection 7. Patients who have other malignancies 8. Patients who are unable to keep protocol due to psychiatric, familial, social or traffic disadvantage 9. Patients who have metals inside the body near (within 10 cm) the lesion where alternative magnetic field is put 10. Patients who have active asthma, or have had severe anaphylaxis before. 11. Patients who are judged inappropriate to be enrolled in this study by the doctor in charge
研究者
相似试验
尚未招募
不适用
A Multi-Center, Randomized Controlled Trial of Heat-Sensitive Moxibustion in the Treatment of Knee OsteoarthritisKnee osteoarthritisITMCTR2000003317The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
未知
1 期
Phase I/II study of adoptive immunotherapy using cytotoxic T cells specific for minor histocompatibility antigen restricted to hematopoietic cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantatio1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CMJPRN-C000000162Aichi Cancer Center30
已完成
1 期
Phase I/II Trial of a novel mild hyperthermia using Oncothermia (EHY-2000) and TS-1/Docetaxel in the treatment of peritoneal metastatic gastric cancerGastric cancerJPRN-UMIN000022420Chiba University33
进行中（未招募）
不适用
A Phase I/II Study of Immunotherapy with Subcutaneous Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lyphocytic LeukemiaEUCTR2008-000434-47-FRImmunomedics, Inc.46
未知
1 期
Phase I/II study of adoptive immunotherapy using predetermined minor histocompatibility antigen-specific cytotoxic T cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantation.1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CMJPRN-C000000161Aichi Cancer Center30